A patient-controlled health identity layer that bridges disconnected NHS systems. One token. Distributed access. Real-time clinical data at point of care.
94% of NHS trusts have electronic patient records. All 42 ICBs have shared care records. The NHS App had 62.3 million logins in November 2025 alone. Yet the system still fails patients at every transition point.
The Darzi Report (Sep 2024) declared the NHS is "in the foothills of digital transformation." The PM pledged a "digital NHS." But the last time government tried this — the NPfIT (2002) — it cost £12.7 billion and was abandoned. The Health Foundation estimates full digitisation needs £21 billion over 5 years, more than double the £10bn committed.
In anatomy, fascia is the continuous web of tissue that connects every muscle, organ, and nerve. Without it, individual organs function in isolation. With it, the body works as one system.
The NHS has the same problem. Hospitals, GPs, community services — all have digital records. But they're isolated. No connective layer. Patients fall through the gaps.
Fascia is that missing layer. It connects everything — without replacing anything.
The name also reflects the founder's background: a PhD in Tissue Engineering and 9 years in medical devices. Literal, functional, instantly recognisable to clinicians.
| Player | Type | Scale | Model | Critical gap |
|---|---|---|---|---|
| Fascia | Patient health passport | Pre-launch | Patient-initiated | ✓ Our space |
| Patients Know Best | Personal health record | 5.6M users | Provider-deployed | Can't self-aggregate |
| Epic MyChart | Patient portal | 10+ NHS trusts | Vendor-locked | Epic-only. No GP data |
| NHS App | National platform | 62M logins/mo | Government-built | GP only. Read-only. SPR 2028+ |
| Oracle Health | EPR vendor | 25% NHS market | Institutional | No cross-vendor portability |
| InterSystems | Integration engine | ~60% of trusts | Backend | No patient-facing layer |
| Better (openEHR) | Vendor-neutral CDR | Scotland NDP | Trust-deployed | Not patient-initiated |
| OneRecord (US) | Record aggregator | US only | FHIR-based | Vaccination-focused. No UK |
| Apple Health | Consumer app | 2 UK trusts | Consumer device | Minimal NHS integration |
19.6% CAGR · Grand View Research
+66% growth over 4 years
NHS operations/commissioning background or commercial health-system sales. Understands ICS procurement. Opens doors at trust CIO level.
QR-based token, authenticated via NHS Login (OIDC). Triggers FHIR R4 API calls to connected providers using UK Core profiles.
Data doesn't move. Distributed access — query and display, not copy and store. ~15 seconds to structured summary.
Nobody owns this space. PKB is provider-deployed. Epic MyChart is vendor-locked. EPR vendors serve institutions. Apple Health stuck at 2 UK trusts.
1. SaaS to trusts/ICSs ~£2–5/patient/yr. 2. Private provider connections £500–2k/mo. 3. Insurance verification per-use. 4. Population health analytics licensing.
SPR in "test and learn." No architecture decided. Earliest 2028. NPfIT cost £12.7bn and failed.
9 years under ISO 13485/14971, FDA. Compliance: DSPT, DCB0129, DTAC, UK GDPR. Distributed = we never hold data.
EPR vendors build roads. Fascia builds Google Maps. We make their systems more valuable.
Week 1: 15–20 CIO/clinician interviews. Week 2: Working PoC on NHS FHIR Sandbox. Week 3: First ICS pilot proposal + SBRI application.

PhD, Tissue Engineering — DePuy Synthes / J&J. Custom biomechanical simulation for chondrolabral hip damage. Published in PLOS ONE. Sole biomedical engineer at Proxisense — melanoma biosensor from concept to NHS trials. 98% measurement improvement.
Senior Systems Engineer — ANGLE Plc. Parsortix — first FDA-approved circulating tumour cell capture. Led FMEA processes, validation, software dev. Founded Melement — revenue-generating web design agency.
No architecture. No procurement. Health Foundation estimates £21bn needed.
All content, concepts, business strategies, technical architecture descriptions, market analysis, revenue models, and any other materials presented on this website (collectively, the "Materials") are the exclusive intellectual property of Mudit Dubey ("the Author"). The Materials are protected by copyright law, trade secret law, and other intellectual property rights under the laws of England and Wales and international treaties.
By accessing this document, you agree that you will not:
The Materials constitute confidential and proprietary information. Access is granted solely to the intended recipient on a need-to-know basis. The recipient agrees to maintain strict confidentiality and to not disclose, discuss, or share the Materials or their contents with any person or entity without the prior written consent of the Author.
Viewing this document does not grant any licence, express or implied, under any intellectual property right. No right to use, reproduce, or exploit the business concept, technical approach, or any associated innovations is conveyed by access to these Materials.
These Materials have been independently conceived and developed by the Author. Timestamped records of development, including version history and dated communications, are maintained as evidence of prior art. Any unauthorised use of these concepts may constitute misappropriation of trade secrets and/or copyright infringement.
The Materials are provided "as is" for informational purposes. While the Author has made reasonable efforts to ensure the accuracy of market data and statistics, no warranties are made regarding completeness or accuracy. The Author shall not be liable for any decisions made based on these Materials.
These terms are governed by the laws of England and Wales. Any disputes shall be subject to the exclusive jurisdiction of the courts of England and Wales.
For permissions, licensing, or enquiries: mudit.d@hotmail.co.uk
© 2026 Mudit Dubey. All rights reserved.
Mudit Dubey, trading as Fascia Health, is the data controller for personal data collected through this website. Contact: mudit.d@hotmail.co.uk.
This website collects minimal data:
This website loads fonts from Google Fonts and images from Unsplash. These third-party services may process limited technical data (e.g., IP address) according to their own privacy policies. No data is shared with these services by us.
Where personal data is processed, the legal basis is legitimate interest (Article 6(1)(f) UK GDPR) — specifically, the interest of the Author in protecting confidential intellectual property and controlling access to proprietary business materials.
Session authentication data is cleared when you close your browser tab. No persistent data is stored.
Under UK GDPR, you have the right to access, rectify, erase, restrict processing, and port your data. As this website collects no personal data, these rights are unlikely to apply. For any queries, contact: mudit.d@hotmail.co.uk.
This policy may be updated. The "last updated" date reflects the most recent version.
© 2026 Mudit Dubey. All rights reserved.
STRICTLY CONFIDENTIAL — DO NOT DISTRIBUTE
This document and all Materials contained herein are the confidential and proprietary property of Mudit Dubey.
This document has been shared exclusively with specifically identified individuals for the sole purpose of evaluating the Fascia Health concept. If you have received access to this document in error, you must notify the Author immediately at mudit.d@hotmail.co.uk and destroy all copies.
By accessing this document, you acknowledge and agree:
Unauthorised disclosure, reproduction, or use of these Materials may result in legal action for breach of confidence, copyright infringement, and/or misappropriation of trade secrets. The Author reserves all rights to seek injunctive relief, damages, and costs.
The business concept, technical architecture, market positioning, and all associated innovations described in these Materials were independently conceived and developed by Mudit Dubey. Comprehensive timestamped records — including version-controlled documents, dated research notes, and third-party communications — are maintained as evidence of authorship and priority of invention.
If you have questions about permitted use, or wish to discuss collaboration, licensing, or partnership, please contact: mudit.d@hotmail.co.uk
© 2026 Mudit Dubey. All rights reserved. All intellectual property rights are asserted.